Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2025-12-24 @ 7:18 PM
NCT ID:
NCT03925103
Eligibility Criteria:
Inclusion Criteria:
* Clinical NSCLC early stage (stage I-II).
* Both forced expiratory volume in one second (FEV1) and diffusion capacity of carbon monoxide (DLCO)\>60%
* Both predicted postoperative (PPO) FEV1 and PPO DLCO \>35%
* American Society of Anesthesia (ASA) score\<=2
* Body mass index (BMI) \>18 \<28
Exclusion Criteria:
* Clinical NSCLC stage\> II
* History of Neoadjuvant chemotherapy or radiotherapy
* Radiologic evidence of extensive pleural adhesions.
* Age \<18 or \>80 years.
* Patients with previous pleurodesis or thoracotomy in the affected hemithorax.
* Patients who will undergo surgical lung resection other than lobectomy.
* Patients with severe comorbidity contraindicating lobectomy.
* Patients refusal or noncompliance to general surgery and one-lung ventilation.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03925103
Study Brief:
Protocol Section:
NCT03925103